FindTrial
Sign In

Identification of clinical biomarkers for adjuvant chemotherapy for gastric cancer after D2 dissection by analyses of individual patients' data from large randomized controlled trials

Identification of clinical biomarkers for adjuvant chemotherapy for gastric cancer after D2 dissection by analyses of individual patients' data from large randomized controlled trials - Clinical biomarker study for adjuvant chemotherapy for gastric cancer after D2 surgery in RCTs

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000028411
Enrollment
3521
Registered
2017-07-30
Start date
2017-09-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric cancer

Interventions

None listed

Sponsors

Tsuboi Cancer Center Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: randomized patients

Exclusion criteria

Exclusion criteria: patients with no data

Design outcomes

Primary

MeasureTime frame
relapse-free survival—

Secondary

MeasureTime frame
overall survival, toxicities and compliance—

Countries

Japan

Contacts

Public ContactAkira Tsuburaya

Tsuboi Cancer Center Hospital Surgery

tuburayaa@gmail.com080-24946-0808

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026